John DeMay has been appointed president, Astellas US Technologies Inc. (AUST).
Robert H. Ring, Ph.D., was appointed CEO and Jeffrey Stevenson was made chairman of the board of directors for Vencerx Therapeutics.
Mark Fladrich has taken over the position of chief commercial officer at the Grünenthal Group and now is responsible for the entire global commercial organization.
Michael McMyne joined Valeant Pharmaceuticals International Inc.’s dermatology division as VP of sales, and Stacey Williams joined as VP of marketing. Additionally, the company announced Lainie Keller joined as VP of corporate communications.
Daniel Menichella is appointed CEO of CureVac Inc., the Boston-based U.S. subsidiary of CureVac AG.
Paul M. Bisaro was made president and CEO as well as a member of the board of directors of Impax Laboratories Inc.
Walter H. Moos, Ph.D., was appointed CEO of ShangPharma Innovation.
MedBridge, a developer of patient engagement and clinical education software, has launched MedBridge GO – a patient-facing mobile app designed to improve adherence to clinician-assigned home exercise programs (HEP).
TG plc and HealthLoop have launched a collaboration on IO Loop, a service that enables patients and their oncologists to stay connected, providing improved pre-procedural patient instructions and ongoing follow-up care outside of the acute care setting.
Smart Meter LLC received 510(k) clearance from FDA and CE Mark in Europe to market the company’s iGlucose Blood Glucose Monitoring System.